P Carrieri

Author PubWeight™ 23.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond) 2011 2.39
2 Blood agar and Mycobacterium tuberculosis: the end of a dogma. J Clin Microbiol 2003 1.64
3 Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS 2001 1.63
4 Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000 1.23
5 Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer 1999 1.20
6 Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment. AIDS Care 2004 1.13
7 Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 1988 1.09
8 Factors associated with efavirenz discontinuation in a large community-based sample of patients. AIDS Care 2004 1.06
9 Cancer risk among female agricultural workers: a multi-center case-control study. Am J Ind Med 1999 0.97
10 Asymptomatic extradural haematomas. Results of a multicenter study of 158 cases in minor head injury. Acta Neurochir (Wien) 1989 0.91
11 Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs. Int J STD AIDS 2001 0.88
12 Gastric cancer surveillance in a high-risk population in tuscany (Central Italy): preliminary results. Digestion 2011 0.85
13 Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. J Viral Hepat 2011 0.85
14 Coxiella burnetii pericarditis: report of 15 cases and review. Clin Infect Dis 1999 0.81
15 Serum Clara cell protein (CC16) in healthy young smokers. Biomarkers 2000 0.80
16 No effect of acetylsalicylic acid on B-thromboglobulin and platelet factor 4 plasma levels in patients with transient ischaemic attacks. Stroke 1987 0.80
17 [Vaccinal coverage for measles and pertussis: a study in 7 regions of Italy]. Ann Ig 1996 0.79
18 [Massive thrombosis of the superior mesenteric artery following splenectomy. A coincidence?]. Minerva Chir 1999 0.79
19 Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions. HIV Med 2013 0.78
20 [Diagnostic problems, pathogenetic hypothesis and therapeutic proposals in Ogilvie's syndrome. Review of 470 observations from the literature and presentation of 5 new cases]. Minerva Chir 1997 0.77
21 Preventive measures reduce exposure to polycyclic aromatic hydrocarbons at a graphite electrode plant. Occup Environ Med 1998 0.76
22 Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination. Vaccine 2011 0.76
23 Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country. Int J STD AIDS 2014 0.75
24 [Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)]. Acta Neurol (Napoli) 1973 0.75
25 [AIDS and the nervous system. Immunologic aspects of the cerebrospinal fluid: personal data and review of the literature]. Acta Neurol (Napoli) 1989 0.75
26 [Platelet aggregation in vasomotor headache]. Boll Soc Ital Biol Sper 1984 0.75
27 [Cerebrospinal fluid electrophoresis: a method of identification of oligoclonal bands. Comparison with the quantitative values of cerebrospinal fluid IgG and with the Link-Tibbling index]. Acta Neurol Quad (Napoli) 1979 0.75
28 [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data]. Acta Neurol (Napoli) 1976 0.75
29 [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes]. Acta Neurol (Napoli) 1977 0.75
30 [Colo-uterine fistula, a complication of sigma diverticulitis]. Minerva Chir 1998 0.75
31 [Antiplatelet activity of picotamide in patients with chronic vascular pathology]. Minerva Cardioangiol 1986 0.75
32 Acute intermittent porphyria and uroporphyrinogen I synthase. Biochemical study of a family. Acta Neurol (Napoli) 1981 0.75
33 Circulating platelet aggregates in cerebrovascular diseases. Preliminary data. Acta Neurol (Napoli) 1981 0.75
34 Platelet function in childhood migraine. Cephalalgia 1985 0.75
35 [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)]. Acta Neurol (Napoli) 1977 0.75
36 Effects of long-term ticlopidine treatment on platelet function and its tolerability in cerebrovascular disease. J Int Med Res 1984 0.75
37 CSF electrophoresis: an adaptation using cellogel RS for identification of protein banding. Boll Soc Ital Biol Sper 1979 0.75
38 A comparative study between indobufen and acetylsalicylic acid on beta-thromboglobulin, platelet factor 4 and platelet aggregation in patients with transient ischemic attacks. Acta Neurol (Napoli) 1984 0.75
39 [Trends in HIV prenatal screening from 1992 to 1994 in South Eastern France]. Rev Epidemiol Sante Publique 1998 0.75
40 [Evaluation of dopamine and serotonin turnover induced by some intravenous anesthetics]. Minerva Anestesiol 1981 0.75
41 Knowledge, attitudes and practice of paediatricians towards measles and pertussis vaccinations in a large Italian region. Ann Ig 1997 0.75
42 Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach. Pharmatherapeutica 1983 0.75
43 [A multidisciplinary approach to the study of cerebrovascular diseases]. Acta Neurol Quad (Napoli) 1980 0.75
44 Hospitalization for depressive syndrome in a cohort of HIV-infected patients contaminated through injecting drug use: MANIF 2000 cohort, France, 1995-1999. AIDS Care 2003 0.75
45 Pulmonary hypertension and systemic lupus erythematosus. Clin Exp Rheumatol 1985 0.75
46 [GABA and diseases of the extrapyramidal system]. Acta Neurol (Napoli) 1978 0.75
47 Cardiovascular risk factors and coronary damage in patients with ischemic brain disease. Acta Neurol (Napoli) 1981 0.75
48 [New tools for preventing and evaluating risk practices for hepatitis C transmission among injection drug users: some reflections on injection rooms and the measurement of risk-taking behaviors]. Rev Epidemiol Sante Publique 2006 0.75
49 [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes]. Acta Neurol (Napoli) 1977 0.75
50 Effect of indinavir and higher CD4+ T-cell count on viral load response after 6 months of highly active antiretroviral therapy. Clin Ther 1999 0.75
51 [Ischemic pathogenesis of acute pancreatitis. A case report]. Minerva Chir 2000 0.75
52 [Hürthle cell carcinoma and "insular" carcinoma: uncommon varieties of thyroid carcinoma]. Minerva Chir 1999 0.75
53 Mianserin versus maprotiline in patients with a depressive syndrome. Acta Neurol (Napoli) 1984 0.75
54 Serum and cerebrospinal fluid enzymes in subarachnoid haemorrhage. Neurol Res 1989 0.75
55 [Determination of HVA and 5-HIAA in epileptic syndromes in basal conditions and after treatment with probenecid]. Acta Neurol Quad (Napoli) 1979 0.75
56 [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system]. Acta Neurol (Napoli) 1977 0.75